Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells

Current Opinion in Immunology

Volumn 25, Issue 3, 2013, Pages 366-372

  Choi, Youn Soo ^a   Yang, Jessica A ^a   Crotty, Shane ^a,b,c  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD134 ANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INDUCIBLE T CELL COSTIMULATOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 12; INTERLEUKIN 21; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 6; PROTEIN KINASE B; SHORT HAIRPIN RNA; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR MAF; TRANSCRIPTION FACTOR T BET;

CD4+ T LYMPHOCYTE; DRUG EFFECT; FOLLICULAR HELPER CD4+ T LYMPHOCYTE; GERMINAL CENTER; HELPER CELL; HUMAN; LISTERIOSIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC CHORIOMENINGITIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-6; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES;

EID: 84879221506     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.04.003     Document Type: Review

References (64)

1. Taubenberger J.K., Reid A.H., Janczewski T.A., Fanning T.G. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond Ser B: Biol Sci 2001, 356:1829-1839.
2. Burton D.R., Ahmed R., Barouch D.H., Butera S.T., Crotty S., Godzik A., Kaufmann D.E., McElrath M.J., Nussenzweig M.C., Pulendran B., et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 2012, 12:396-407.
3. Stamatatos L. HIV vaccine design: the neutralizing antibody conundrum. Curr Opin Immunol 2012, 24:316-323.
4. Jenner E. An Inquiry into the Causes and Effects of the Variolae Vaccinae 1798, Sampson Low, London.
5. Behbehani A.M. The smallpox story: life and death of an old disease. Microbiol Rev 1983, 47:455-509.
6. Amanna I.J., Slifka M.K., Crotty S. Immunity and immunological memory following smallpox vaccination. Immunol Rev 2006, 211:320-337.
7. Victora G.D., Nussenzweig M.C. Germinal centers. Annu Rev Immunol 2012, 30:429-457.
8. Stavnezer J., Guikema J.E.J., Schrader C.E. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008, 26:261-292.
9. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
10. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011, 29:621-663.
11. Johnston R.J., Poholek A.C., Ditoro D., Yusuf I., Eto D., Barnett B., Dent A.L., Craft J., Crotty S. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009, 325:1006-1010.
12. Nurieva R.I., Chung Y., Martinez G.J., Yang X.O., Tanaka S., Matskevitch T.D., Wang Y-H., Dong C. Bcl6 mediates the development of T follicular helper cells. Science 2009, 325:1001-1005.
13. Yu D., Rao S., Tsai L.M., Lee S.K., He Y., Sutcliffe E.L., Srivastava M., Linterman M., Zheng L., Simpson N., et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009, 31:457-468.
14. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002, 39:531-536.
15. Choi Y.S., Eto D., Yang J.A., Lao C., Crotty S. Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation. J Immunol 2013, 190:3049-3053.
16. Heinrich P.C., Behrmann I., Müller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998, 334:297-314.
17. Nurieva R.I., Chung Y., Hwang D., Yang X.O., Kang H.S., Ma L., Wang Y-H., Watowich S.S., Jetten A.M., Tian Q., et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008, 29:138-149.
18. Hotson A.N., Hardy J.W., Hale M.B., Contag C.H., Nolan G.P. The T cell STAT signaling network is reprogrammed within hours of bacteremia via secondary signals. J Immunol 2009, 182:7558-7568.
19. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
20. Ma C.S., Avery D.T., Chan A., Batten M., Bustamante J., Boisson-Dupuis S., Arkwright P.D., Kreins A.Y., Averbuch D., Engelhard D., et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 2012, 119:3997-4008.
21. Liao W., Lin J-X., Wang L., Li P., Leonard W.J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol 2011, 12:551-559.
22. Eto D., Lao C., Ditoro D., Barnett B., Escobar T.C., Kageyama R., Yusuf I., Crotty S. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 2011, 6:e17739.
23. Karnowski A., Chevrier S., Belz G.T., Mount A., Emslie D., D'Costa K., Tarlinton D.M., Kallies A., Corcoran L.M. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J Exp Med 2012, 209:2049-2064.
24. Poholek A.C., Hansen K., Hernandez S.G., Eto D., Chandele A., Weinstein J.S., Dong X., Odegard J.M., Kaech S.M., Dent A.L., et al. In vivo regulation of Bcl6 and T follicular helper cell development. J Immunol 2010, 185:313-326.
25. Crotty S. The 1-1-1 fallacy. Immunol Rev 2012, 247:133-142.
26. Suto A., Kashiwakuma D., Kagami S-I., Hirose K., Watanabe N., Yokote K., Saito Y., Nakayama T., Grusby M.J., Iwamoto I., et al. Development and characterization of IL-21-producing CD4+ T cells. J Exp Med 2008, 205:1369-1379.
27. Asao H., Okuyama C., Kumaki S., Ishii N., Tsuchiya S., Foster D., Sugamura K. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001, 167:1-5.
28. Linterman M.A., Beaton L., Yu D., Ramiscal R.R., Srivastava M., Hogan J.J., Verma N.K., Smyth M.J., Rigby R.J., Vinuesa C.G. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 2010, 207:353-363.
29. Choi Y.S., Kageyama R., Eto D., Escobar T.C., Johnston R.J., Monticelli L., Lao C., Crotty S. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011, 34:932-946.
30. Goenka R., Barnett L.G., Silver J.S., O'Neill P.J., Hunter C.A., Cancro M.P., Laufer T.M. Cutting edge: dendritic cell-restricted antigen presentation initiates the follicular helper T cell program but cannot complete ultimate effector differentiation. J Immunol 2011, 187:1091-1095.
31. Ma C.S., Suryani S., Avery D.T., Chan A., Nanan R., Santner-Nanan B., Deenick E.K., Tangye S.G. Early commitment of naïve human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL-12. Immunol Cell Biol 2009, 87:590-600.
32. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
33. Nakayamada S., Kanno Y., Takahashi H., Jankovic D., Lu K.T., Johnson T.A., Sun H-W., Vahedi G., Hakim O., Handon R., et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 2011, 35:919-931.
34. Lee S.K., Silva D.G., Martin J.L., Pratama A., Hu X., Chang P-P., Walters G., Vinuesa C.G. Interferon-γ excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity 2012, 37:880-892.
35. Vinuesa C.G., Cook M.C., Angelucci C., Athanasopoulos V., Rui L., Hill K.M., Yu D., Domaschenz H., Whittle B., Lambe T., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005, 435:452-458.
36. O'Shea J.J., Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012, 36:542-550.
37. Gigoux M., Shang J., Pak Y., Xu M., Choe J., Mak T.W., Suh W-K. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proc Natl Acad Sci U S A 2009, 106:20371-20376.
38. Hu H., Wu X., Jin W., Chang M., Cheng X., Sun S-C. Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development. Proc Natl Acad Sci U S A 2011, 108:12827-12832.
39. Rolf J., Bell S.E., Kovesdi D., Janas M.L., Soond D.R., Webb L.M.C., Santinelli S., Saunders T., Hebeis B., Killeen N., et al. Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J Immunol 2010, 185:4042-4052.
40. So T., Choi H., Croft M. OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling. J Immunol 2011, 186:3547-3555.
41. Rudd C.E., Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 2003, 3:544-556.
42. Ise W., Kohyama M., Schraml B.U., Zhang T., Schwer B., Basu U., Alt F.W., Tang J., Oltz E.M., Murphy T.L., et al. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat Immunol 2011, 12:536-543.
43. Bauquet A.T., Jin H., Paterson A.M., Mitsdoerffer M., Ho I-C., Sharpe A.H., Kuchroo V.K. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol 2009, 10:167-175.
44. Kroenke M.A., Eto D., Locci M., Cho M., Davidson T., Haddad E.K., Crotty S. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 2012, 188:3734-3744.
45. Bollig N., Brüstle A., Kellner K., Ackermann W., Abass E., Raifer H., Camara B., Brendel C., Giel G., Bothur E., et al. Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Proc Natl Acad Sci U S A 2012, 109:8664-8669.
46. Kwon H., Thierry-Mieg D., Thierry-Mieg J., Kim H-P., Oh J., Tunyaplin C., Carotta S., Donovan C.E., Goldman M.L., Tailor P., et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 2009, 31:941-952.
47. Streeck H., D'Souza M.P., Littman D.R., Crotty S. Harnessing CD4(+) T cell responses in HIV vaccine development. Nat Med 2013, 19:143-149.
48. Pepper M., Pagán A.J., Igyártó B.Z., Taylor J.J., Jenkins M.K. Opposing signals from the bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 2011, 35:583-595.
49. Choi Y.S., Yang J.A., Yusuf I., Johnston R.J., Greenbaum J., Peters B., Crotty S. Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J Immunol 2013, 190:4014-4026.
50. Gilmour K.C., Pine R., Reich N.C. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci U S A 1995, 92:10772-10776.
51. Gong D., Malek T.R. Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production. J Immunol 2007, 178:242-252.
52. Johnston R.J., Choi Y.S., Diamond J.A., Yang J.A., Crotty S. STAT5 is a potent negative regulator of TFH cell differentiation. J Exp Med 2012, 209:243-250.
53. Oestreich K.J., Mohn S.E., Weinmann A.S. Molecular mechanisms that control the expression and activity of Bcl-6 in T(H)1 cells to regulate flexibility with a T(FH)-like gene profile. Nat Immunol 2012, 13:405-411.
54. Stahl M., Dijkers P.F., Kops G.J.P.L., Lens S.M.A., Coffer P.J., Burgering B.M.T., Medema R.H. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 2002, 168:5024-5031.
55. Kousteni S. FoxO1, the transcriptional chief of staff of energy metabolism. Bone 2012, 50:437-443.
56. Kerdiles Y.M., Stone E.L., Beisner D.L., Mcgargill M.A., Ch'en I.L., Stockmann C., Katayama C.D., Hedrick S.M. Foxo transcription factors control regulatory T cell development and function. Immunity 2010, 33:890-904.
57. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
58. Kops G.J., de Ruiter N.D., De Vries-Smits A.M., Powell D.R., Bos J.L., Burgering B.M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999, 398:630-634.
59. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002, 2:410-416.
60. Kim H., Hawley T.S., Hawley R.G., Baumann H. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol Cell Biol 1998, 18:1525-1533.
61. Nicholson S.E., De Souza D., Fabri L.J., Corbin J., Willson T.A., Zhang J.G., Silva A., Asimakis M., Farley A., Nash A.D., et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A 2000, 97:6493-6498.
62. Jacobson N.G., Szabo S.J., Weber-Nordt R.M., Zhong Z., Schreiber R.D., Darnell J.E., Murphy K.M. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995, 181:1755-1762.
63. Wilson-Welder J.H., Torres M.P., Kipper M.J., Mallapragada S.K., Wannemuehler M.J., Narasimhan B. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 2009, 98:1278-1316.
64. Mata-Haro V., Cekic C., Martin M., Chilton P.M., Casella C.R., Mitchell T.C. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007, 316:1628-1632.